{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:16:23Z","timestamp":1788480983628,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Stereotactic Ablative Body Radiotherapy (SABR) is a non-invasive treatment which allows delivery of an ablative radiation dose with high accuracy and precision. SABR is an established treatment for both primary and secondary liver malignancies, and technological advances have improved its efficacy and safety. Respiratory motion management to reduce tumour motion and image guidance to achieve targeting accuracy are crucial elements of liver SABR. This phase II multi-institutional TROG 17.03 study, <jats:bold>L<\/jats:bold>iver <jats:bold>A<\/jats:bold>blative <jats:bold>R<\/jats:bold>adiotherapy using <jats:bold>K<\/jats:bold>ilovoltage intrafraction monitoring (LARK), aims to investigate and assess the dosimetric impact of the KIM real-time image guidance technology. KIM utilises standard linear accelerator equipment and therefore has the potential to be a widely available real-time image guidance technology for liver SABR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Forty-six patients with either hepatocellular carcinoma or oligometastatic disease to the liver suitable for and treated with SABR using Kilovoltage Intrafraction Monitoring (KIM) guidance will be included in the study. The dosimetric impact will be assessed by quantifying accumulated patient dose distribution with or without the KIM intervention. The patient treatment outcomes of local control, toxicity and quality of life will be measured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Liver SABR is a highly effective treatment, but precise dose delivery is challenging due to organ motion. Currently, there is a lack of widely available options for performing real-time tumour localisation to assist with accurate delivery of liver SABR. This study will provide an assessment of the impact of KIM as a potential solution for real-time image guidance in liver SABR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>This trial was registered on December 7th 2016 on ClinicalTrials.gov under the trial-ID <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02984566?term=NCT02984566.&amp;draw=2&amp;rank=1\">NCT02984566<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08184-x","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T11:03:03Z","timestamp":1620039783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4325-349X","authenticated-orcid":false,"given":"Yoo Young Dominique","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doan Trang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Moodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"McMaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizaveta Mitkina","family":"Tabaksblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esben","family":"Worm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pryor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Hardcastle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val","family":"Gebski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Keall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"issue":"6","key":"8184_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/COC.0b013e3180ca7cb1","volume":"30","author":"BK Chang","year":"2007","unstructured":"Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol. 2007;30(6):637\u201344. https:\/\/doi.org\/10.1097\/COC.0b013e3180ca7cb1.","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"8184_CR2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/COC.0000000000000169","volume":"40","author":"SL Lewis","year":"2017","unstructured":"Lewis SL, Porceddu S, Nakamura N, Palma DA, Lo SS, Hoskin P, et al. Definitive stereotactic body radiotherapy (SBRT) for extracranial oligometastases: an international survey of >1000 radiation oncologists. Am J Clin Oncol. 2017;40(4):418\u201322. https:\/\/doi.org\/10.1097\/COC.0000000000000169.","journal-title":"Am J Clin Oncol"},{"issue":"11","key":"8184_CR3","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jama.2010.261","volume":"303","author":"R Timmerman","year":"2010","unstructured":"Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070\u20136. https:\/\/doi.org\/10.1001\/jama.2010.261.","journal-title":"JAMA."},{"issue":"3","key":"8184_CR4","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.ijrobp.2011.07.020","volume":"82","author":"M Hoyer","year":"2012","unstructured":"Hoyer M, Swaminath A, Bydder S, Lock M, Mendez Romero A, Kavanagh B, et al. Radiotherapy for liver metastases: a review of evidence. Int J Radiat Oncol Biol Phys. 2012;82(3):1047\u201357. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.07.020.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8184_CR5","first-page":"979214","volume":"2011","author":"WA Hall","year":"2011","unstructured":"Hall WA, Stapleford LJ, Hadjipanayis CG, Curran WJ, Crocker I, Shu HK. Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review. Int J Surg Oncol. 2011;2011:979214.","journal-title":"Int J Surg Oncol"},{"issue":"3","key":"8184_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.semradonc.2017.02.002","volume":"27","author":"LJ Murray","year":"2017","unstructured":"Murray LJ, Dawson LA. Advances in stereotactic body radiation therapy for hepatocellular carcinoma. Semin Radiat Oncol. 2017;27(3):247\u201355. https:\/\/doi.org\/10.1016\/j.semradonc.2017.02.002.","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"8184_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8\u201310. https:\/\/doi.org\/10.1200\/JCO.1995.13.1.8.","journal-title":"J Clin Oncol"},{"issue":"5","key":"8184_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1200\/JCO.2015.61.4925","volume":"34","author":"DR Wahl","year":"2016","unstructured":"Wahl DR, Stenmark MH, Tao Y, Pollom EL, Caoili EM, Lawrence TS, et al. Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma. J Clin Oncol. 2016;34(5):452\u20139. https:\/\/doi.org\/10.1200\/JCO.2015.61.4925.","journal-title":"J Clin Oncol"},{"key":"8184_CR9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijrobp.2020.03.014","volume":"107","author":"P Keall","year":"2020","unstructured":"Keall P, Nguyen DT, O'Brien R, Hewson E, Ball H, Poulsen P, et al. Real-time image-guided ablative prostate cancer radiation therapy: results from the TROG 15.01 spark trial. Int J Radiat Oncol Biol Phys. 2020;107:530\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8184_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.radonc.2019.11.008","volume":"144","author":"PR Poulsen","year":"2020","unstructured":"Poulsen PR, Murtaza G, Worm ES, Ravkilde T, O'Brien R, Grau C, et al. Simulated multileaf collimator tracking for stereotactic liver radiotherapy guided by kilovoltage intrafraction monitoring: Dosimetric gain and target overdose trends. Radiother Oncol. 2020;144:93\u2013100. https:\/\/doi.org\/10.1016\/j.radonc.2019.11.008.","journal-title":"Radiother Oncol"},{"issue":"1","key":"8184_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13014-019-1300-6","volume":"14","author":"M Gargett","year":"2019","unstructured":"Gargett M, Haddad C, Kneebone A, Booth JT, Hardcastle N. Clinical impact of removing respiratory motion during liver SABR. Radiat Oncol. 2019;14(1):93. https:\/\/doi.org\/10.1186\/s13014-019-1300-6.","journal-title":"Radiat Oncol"},{"issue":"1","key":"8184_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1748-717X-7-92","volume":"7","author":"J Boda-Heggemann","year":"2012","unstructured":"Boda-Heggemann J, Dinter D, Weiss C, Frauenfeld A, Siebenlist K, Attenberger U, et al. Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results. Radiat Oncol. 2012;7(1):92. https:\/\/doi.org\/10.1186\/1748-717X-7-92.","journal-title":"Radiat Oncol"},{"issue":"2","key":"8184_CR13","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1016\/S1470-2045(20)30034-6","volume":"21","author":"JS Witt","year":"2020","unstructured":"Witt JS, Rosenberg SA, Bassetti MF. MRI-guided adaptive radiotherapy for liver tumours: visualising the future. Lancet Oncol. 2020;21(2):e74\u201382. https:\/\/doi.org\/10.1016\/S1470-2045(20)30034-6.","journal-title":"Lancet Oncol"},{"issue":"2","key":"8184_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ijrobp.2018.02.010","volume":"101","author":"ES Worm","year":"2018","unstructured":"Worm ES, Hoyer M, Hansen R, Larsen LP, Weber B, Grau C, et al. A prospective cohort study of gated stereotactic liver radiation therapy using continuous internal electromagnetic motion monitoring. Int J Radiat Oncol Biol Phys. 2018;101(2):366\u201375. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.02.010.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"8184_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ijrobp.2016.01.033","volume":"95","author":"J Bertholet","year":"2016","unstructured":"Bertholet J, Worm ES, Fledelius W, Hoyer M, Poulsen PR. Time-resolved Intrafraction target translations and rotations during stereotactic liver radiation therapy: implications for marker-based localization accuracy. Int J Radiat Oncol Biol Phys. 2016;95(2):802\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.01.033.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"8184_CR16","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/aaae8b","volume":"63","author":"J Bertholet","year":"2018","unstructured":"Bertholet J, Toftegaard J, Hansen R, Worm ES, Wan H, Parikh PJ, et al. Automatic online and real-time tumour motion monitoring during stereotactic liver treatments on a conventional linac by combined optical and sparse monoscopic imaging with kilovoltage x-rays (COSMIK). Phys Med Biol. 2018;63(5):055012. https:\/\/doi.org\/10.1088\/1361-6560\/aaae8b.","journal-title":"Phys Med Biol"},{"issue":"11","key":"8184_CR17","doi-asserted-by":"publisher","first-page":"111712","DOI":"10.1118\/1.4898119","volume":"41","author":"JA Ng","year":"2014","unstructured":"Ng JA, Booth JT, O'Brien RT, Colvill E, Huang CY, Poulsen PR, et al. Quality assurance for the clinical implementation of kilovoltage intrafraction monitoring for prostate cancer VMAT. Med Phys. 2014;41(11):111712. https:\/\/doi.org\/10.1118\/1.4898119.","journal-title":"Med Phys"},{"issue":"17","key":"8184_CR18","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1088\/0031-9155\/56\/17\/001","volume":"56","author":"Y Seppenwoolde","year":"2011","unstructured":"Seppenwoolde Y, Wunderink W, Wunderink-van Veen SR, Storchi P, Mendez Romero A, Heijmen BJ. Treatment precision of image-guided liver SBRT using implanted fiducial markers depends on marker-tumour distance. Phys Med Biol. 2011;56(17):5445\u201368. https:\/\/doi.org\/10.1088\/0031-9155\/56\/17\/001.","journal-title":"Phys Med Biol"},{"issue":"8","key":"8184_CR19","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, et al. Stereotactic body radiation therapy: the report of AAPM task group 101. Med Phys. 2010;37(8):4078\u2013101. https:\/\/doi.org\/10.1118\/1.3438081.","journal-title":"Med Phys"},{"issue":"4","key":"8184_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.semradonc.2008.04.001","volume":"18","author":"RD Timmerman","year":"2008","unstructured":"Timmerman RD. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol. 2008;18(4):215\u201322. https:\/\/doi.org\/10.1016\/j.semradonc.2008.04.001.","journal-title":"Semin Radiat Oncol"},{"issue":"5","key":"8184_CR21","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ijrobp.2014.11.028","volume":"91","author":"EC Osmundson","year":"2015","unstructured":"Osmundson EC, Wu Y, Luxton G, Bazan JG, Koong AC, Chang DT. Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract. Int J Radiat Oncol Biol Phys. 2015;91(5):986\u201394. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.11.028.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"8184_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176118","volume":"12","author":"G Oldrini","year":"2017","unstructured":"Oldrini G, Huertas A, Renard-Oldrini S, Taste-George H, Vogin G, Laurent V, et al. Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma. PLoS One. 2017;12(4):e0176118. https:\/\/doi.org\/10.1371\/journal.pone.0176118.","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"8184_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00259-017-3687-3","volume":"44","author":"K Pinker","year":"2017","unstructured":"Pinker K, Riedl C, Weber WA. Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments. Eur J Nucl Med Mol Imaging. 2017;44(Suppl 1):55\u201366. https:\/\/doi.org\/10.1007\/s00259-017-3687-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"8184_CR24","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1118\/1.4754297","volume":"39","author":"PR Poulsen","year":"2012","unstructured":"Poulsen PR, Schmidt ML, Keall P, Worm ES, Fledelius W, Hoffmann L. A method of dose reconstruction for moving targets compatible with dynamic treatments. Med Phys. 2012;39(10):6237\u201346. https:\/\/doi.org\/10.1118\/1.4754297.","journal-title":"Med Phys"},{"issue":"1","key":"8184_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","volume":"10","author":"R Simon","year":"1989","unstructured":"Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials. 1989;10(1):1\u201310. https:\/\/doi.org\/10.1016\/0197-2456(89)90015-9.","journal-title":"Control Clin Trials"},{"issue":"3","key":"8184_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.radonc.2014.05.007","volume":"111","author":"PR Poulsen","year":"2014","unstructured":"Poulsen PR, Worm ES, Petersen JB, Grau C, Fledelius W, Hoyer M. Kilovoltage intrafraction motion monitoring and target dose reconstruction for stereotactic volumetric modulated arc therapy of tumors in the liver. Radiother Oncol. 2014;111(3):424\u201330. https:\/\/doi.org\/10.1016\/j.radonc.2014.05.007.","journal-title":"Radiother Oncol"},{"issue":"1","key":"8184_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ijrobp.2012.12.017","volume":"86","author":"ES Worm","year":"2013","unstructured":"Worm ES, Hoyer M, Fledelius W, Poulsen PR. Three-dimensional, time-resolved, intrafraction motion monitoring throughout stereotactic liver radiation therapy on a conventional linear accelerator. Int J Radiat Oncol Biol Phys. 2013;86(1):190\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.12.017.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08184-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08184-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08184-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T11:11:17Z","timestamp":1620040277000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08184-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8184"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08184-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study (NCT02984566) has received ethical approval from Western Sydney Local Health District Research Ethics Board on the 24th of October 2016. Written informed consent is obtained from all participants before inclusion.This protocol manuscript is in accordance with SPRIT 2013 recommendations and the corresponding author has completed the checklist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PK is an inventor on an issued patent related to the KIM technology that is licensed from Stanford University to Varian Medical Systems, and an inventor and owner on other filed patents related to the KIM technology that are unlicensed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"494"}}